Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biomet's Q4, FY2011 losses widen on sluggish U.S. sales, $940M writedown
Biomet's Q4, FY2011 losses widen on sluggish U.S. sales, $940M writedown
Biomet's Q4, FY2011 losses widen on sluggish U.S. sales, $940M writedown
Submitted by
admin
on July 19, 2011 - 11:58am
Source:
Mass Device
News Tags:
Biomet
earnings
Headline:
Biomet's Q4, FY2011 losses widen on sluggish U.S. sales, $940M writedown
Do Not Allow Advertisers to Use My Personal information
